BC
OLMA icon

Birchview Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Birchview Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.27M Sell
219,000
-50,000
-19% -$1.11M 1.86% 15
2025
Q4 		$6.72M Buy
269,000
+95,000
+55% +$1.69M 3.94% 6
2025
Q3 		$1.7M Buy
174,000
+40,000
+30% +$240K 1.29% 22
2025
Q2 		$571K Buy
+134,000
New +$597K 0.57% 37

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Birchview Capital's OLMA Position: Q1 2026 in Review

Birchview Capital reduced its Olema Pharmaceuticals (OLMA) stake by 19% in Q1 2026, selling an estimated $1.11M and leaving 219,000 shares worth $3.27M. The position accounts for 1.86% of the portfolio, ranked #15.

Birchview Capital first reported a position in OLMA in Q2 2025 and has held it in 4 quarters since. The position peaked at $6.72M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Birchview Capital held 219,000 shares of Olema Pharmaceuticals worth $3.27M as of Q1 2026.
  • Birchview Capital sold 50,000 Olema Pharmaceuticals shares in Q1 2026, an estimated $1.11M.
  • Olema Pharmaceuticals made up 1.86% of Birchview Capital's portfolio in Q1 2026, its #15 holding.
  • Birchview Capital first reported a position in Olema Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Birchview Capital's Olema Pharmaceuticals position peaked at $6.72M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Birchview Capital's 13F filing for Q1 2026, filed 15 May 2026.